Magnolia Hospice in Conyers, Georgia

Magnolia Hospice is a medicare-certified hospice facility in Conyers, Georgia. It is a for profit hospice and this hospice is a Freestanding Hospice. It is located at 923 Center Street in Conyers, Georgia. You can reach out to the office of Magnolia Hospice via phone at (770) 483-9111.

Magnolia Hospice is first approved in October, 2014 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 111754. Atlanta is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Magnolia Hospice
923 Center Street, Conyers, GA, 30012
(770) 483-9111

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago

Map and Direction



Hospice Profile

NameMagnolia Hospice
Location923 Center Street, Conyers, Georgia
Hospice ID111754
CategoryFreestanding Hospice
Ownership TypeProprietary - Corporation
Profit TypeFOR PROFIT
SSA county code841

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Magnolia Hospice from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1396169074
Organization NameMagnolia Hospice, Llc
Address1374 Manchester Dr Ne Conyers, Georgia, 30012
Phone Number(770)483-9111

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago


NPI Number1588625925
Organization NameHillcrest Hospice, Inc
Address1374 Manchester Dr Ne Conyers, Georgia, 30012
Phone Number(678)413-4040

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago


NPI Number1831145424
Organization NameIn Home Health Llc
Address1374 Manchester Dr Ne Conyers, Georgia, 30012
Phone Number(678)413-4040

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago


Quality of Patient Care at Magnolia Hospice

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Magnolia Hospice has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice careNot Available98.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice careNot Available93.6
Patients who were checked for pain at the beginning of hospice careNot Available93.9
Patients who got a timely and thorough pain assessment when pain was identified as a problemNot Available77.7
Patients who were checked for shortness of breath at the beginning of hospice careNot Available97.3
Patients who got timely treatment for shortness of breathNot Available94.6
Patients taking opioid pain medication who were offered care for constipationNot Available93.3

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago


Services Provided by Magnolia Hospice:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Magnolia Hospice below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Nursing Service
    • Other Services

  • Under Arrangement
    • Medical Supply Service
    • Occupational Therapy
    • Physician Service
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Magnolia Hospice
Home Health Aides2
Counselors0.25
Licensed Practical or Vocational Nurses0.25
Medical Social Workers 0.25
Physicians0.75
Registered Nurses3.5
Other Personnel2
Total Employees9

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago


Number of Full-time equivalent Volunteers:

Counselors1
Total Volunteers1

News Archive

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

Insurers reject Obama's proposal for a rate-hike review panel

The health overhaul plan unveiled Monday by President Barack Obama puts the heat on insurers by requiring federal oversight of increases in health insurance premium rates, something the industry has strenuously objected to.

Even with Senate control, Democrats will need buy-in from GOP on key health priorities

Democrats have argued for more generous pandemic relief, more pressure on drugmakers to lower prices and more attention to systemic racism in health care.

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

Inhibition of parvalbumin-expressing prefrontal interneurons triggers fear behaviours

Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.

Read more Medical News

› Verified 8 days ago

Certification Details for Magnolia Hospice:

  • December, 2016 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is in compliance with CMS program requirements based on an acceptable plan for correction of deficiencies.
  • It is eligible to participate in the medicare and/or medicaid program.
  • Blue Cross (south Carolina) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 31, December.

Hospices in Conyers

Regency Southerncare-metro Atlanta
Location: 1051 Culpepper Drive Sw, Conyers, Georgia, 30094
Phone: (770) 483-9111
Magnolia Hospice
Location: 923 Center Street, Conyers, Georgia, 30012
Phone: (770) 483-9111
Hospice Nurses Of Georgia, Llc
Location: 2385 Wall Street Suite 119, Conyers, Georgia, 30013
Phone: (770) 483-9111
Circle Of Angels Hospice Inc
Location: 2817 Highway 212 Sw, Conyers, Georgia, 30094
Phone: (770) 483-9111

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.